Dr. William E Barager , DO
Internal Medicine - Nephrology • Provo, UT
1055 N 500 W, Ste 222
Provo, UT 846043305
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. William Barager is listed in NPPES under Internal Medicine - Nephrology.
-
NPI assigned on June 10, 2006; this date does not establish years in practice.
-
Published CMS data list 3,358 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 36415 — Insertion of needle into vein for collection of blood sample: 474 service units.
- 80069 — Kidney function blood test panel: 450 service units.
- G2211 — Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 357 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 28 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,597 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Calcitriol — 266 prescription fills, including refills.
- Amlodipine Besylate — 147 prescription fills, including refills.
- Valsartan — 121 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 37 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Internal Medicine - Nephrology in Utah (2024, 64 clinicians with data). Median for this group: 739. Middle half: 354 to 1,041.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 5,844 in 2020 to 3,358 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1055 N 500 W
Ste 222
Provo, UT 846043305
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Revere Health Pc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
At Still University Of Health Sciences, College Of Osteo Med, Kirksville
2001
What Public CMS Data Show
Internal Medicine - Nephrology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
450 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $160,868 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $126,787 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
2,902 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$165,527 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,416.99 across 78 records.
By nature of payment
- Food and Beverage: $1,352.45 across 76 records.
- Education: $64.54 across 2 records.
Reporting-company totals (3 largest of 19)
- Bayer Healthcare Pharmaceuticals Inc.: $254.35 across 19 records.
- ANI Pharmaceuticals, Inc.: $179.21 across 11 records.
- Amgen Inc.: $151.79 across 12 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
25 years (graduated 2001)
CMS Doctors and Clinicians data list 2001 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Barager has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Barager as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Provo and Utah
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Internal Medicine - Nephrology in Utah (2024, 64 clinicians with data). Median for this group: 739. Middle half: 354 to 1,041.
Too few clinicians listed under Internal Medicine - Nephrology in Provo have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 85% of clinicians listed under Internal Medicine - Nephrology in Utah (2024, 64 clinicians with data). Median for this group: $86,868. Middle half: $41,903 to $135,291.
Too few clinicians listed under Internal Medicine - Nephrology in Provo have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 85% of clinicians listed under Internal Medicine - Nephrology in Utah (2024, 64 clinicians with data). Median for this group: $64,546. Middle half: $31,788 to $106,176.
Too few clinicians listed under Internal Medicine - Nephrology in Provo have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Internal Medicine - Nephrology in Utah (2024, 63 clinicians with data). Median for this group: 675. Middle half: 219 to 1,139.
Too few clinicians listed under Internal Medicine - Nephrology in Provo have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 75% of clinicians listed under Internal Medicine - Nephrology in Utah (2024, 63 clinicians with data). Median for this group: $69,913. Middle half: $19,254 to $141,020.
Too few clinicians listed under Internal Medicine - Nephrology in Provo have Medicare Part D data for 2024 to compare.
6 active clinicians are listed under Internal Medicine - Nephrology with a practice address in Provo, UT (83 in Utah).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 43% from 5,844 in 2020 to 3,358 in 2024.
- 2020: 5,844
- 2021: 2,951
- 2022: 2,277
- 2023: 2,897
- 2024: 3,358
-
Medicare-allowed amount
Medicare-allowed amount decreased 47% from $301,988 in 2020 to $160,868 in 2024.
- 2020: $301,988
- 2021: $201,977
- 2022: $145,973
- 2023: $175,177
- 2024: $160,868
-
Paid by Medicare
Paid by Medicare decreased 49% from $246,330 in 2020 to $126,787 in 2024.
- 2020: $246,330
- 2021: $159,657
- 2022: $116,432
- 2023: $139,073
- 2024: $126,787
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 1,689 in 2020 and 1,597 in 2024.
- 2020: 1,689
- 2021: 1,370
- 2022: 1,291
- 2023: 1,386
- 2024: 1,597
-
30-day fills
30-day fills stayed about the same: 2,803 in 2020 and 2,902 in 2024.
- 2020: 2,803
- 2021: 2,294
- 2022: 2,273
- 2023: 2,585
- 2024: 2,902
-
Part D drug cost
Part D drug cost varied from year to year: $178,919 in 2020 and $165,527 in 2024.
- 2020: $178,919
- 2021: $88,563
- 2022: $71,495
- 2023: $115,013
- 2024: $165,527
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $750.99 in 2021 to $1,416.99 in 2025.
- 2021: $750.99
- 2022: $1,474.20
- 2023: $3,178.78
- 2024: $2,037.02
- 2025: $1,416.99
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 78 records totaling $1,416.99.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $98.34 |
| Travere Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $39.28 |
| Novo Nordisk Inc |
Education
In-kind items and services
|
Ozempic | General | $32.27 |
| Novo Nordisk Inc |
Education
In-kind items and services
|
Ozempic | General | $32.27 |
| Travere Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $32.14 |
| AKEBIA THERAPEUTICS INC |
Food and Beverage
In-kind items and services
|
Vafseo | General | $29.97 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
ULTOMIRIS | General | $29.72 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $29.24 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $28.74 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Vanrafia | General | $27.85 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TAVNEOS | General | $27.22 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
FABRAZYME | General | $25.77 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $25.70 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PURIFIED CORTROPHIN GEL | General | $25.63 |
| Travere Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $24.40 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PURIFIED CORTROPHIN GEL | General | $24.35 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PURIFIED CORTROPHIN GEL | General | $24.10 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $24.04 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
LOKELMA | General | $24.00 |
| Ardelyx, Inc. |
Food and Beverage
In-kind items and services
|
IBSRELA | General | $23.69 |
| Travere Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $22.13 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $21.62 |
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $20.97 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $20.42 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $20.41 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
36415
Insertion of needle into vein for collection of blood sample
|
474 | 213 | $15.90 | $8.60 |
|
80069
Kidney function blood test panel
|
450 | 213 | $19.00 | $8.48 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
357 | 260 | $33.67 | $15.57 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
323 | 237 | $215.65 | $121.30 |
|
82570
Creatinine level to test for kidney function or muscle injury
|
225 | 140 | $9.00 | $5.02 |
|
82043
Urine microalbumin (protein) level
|
219 | 136 | $13.00 | $5.64 |
|
83970
Parathormone (parathyroid hormone) level
|
199 | 130 | $87.00 | $40.22 |
|
85018
Blood count, hemoglobin
|
169 | 109 | $7.00 | $2.32 |
|
90960
Dialysis services, 4 or more physician visits per month (20 years or older)
|
143 | 32 | $686.12 | $335.57 |
|
82306
Vitamin d-3 level
|
123 | 99 | $62.00 | $28.81 |
|
83036
Hemoglobin a1c level
|
119 | 68 | $20.97 | $9.52 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
80 | 45 | $200.95 | $112.71 |
|
81003
Automated urinalysis test
|
63 | 51 | $5.97 | $2.17 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
54 | 54 | $281.33 | $158.85 |
|
83735
Magnesium level
|
49 | 31 | $14.00 | $6.38 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
46 | 23 | $303.96 | $166.51 |
|
90961
Dialysis services, 2-3 physician visits per month (20 years or older)
|
36 | 20 | $569.33 | $276.28 |
|
85025
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
|
32 | 22 | $13.84 | $7.41 |
|
90935
Hemodialysis procedure with physician evaluation
|
31 | 21 | $142.00 | $67.24 |
|
81001
Manual urinalysis test with examination using microscope, automated
|
26 | 23 | $16.00 | $2.99 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
25 | 21 | $133.84 | $74.74 |
|
83540
Iron level
|
22 | 19 | $14.00 | $6.34 |
|
83550
Iron binding capacity
|
22 | 19 | $19.00 | $8.57 |
|
82728
Ferritin (blood protein) level
|
21 | 18 | $29.00 | $13.36 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
15 | 14 | $152.80 | $84.71 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Calcitriol | Calcitriol | 266 | 11,740 | $3,461.81 | 65 |
| Amlodipine Besylate | Amlodipine Besylate | 147 | 10,410 | $1,242.66 | 44 |
| Valsartan | Valsartan | 121 | 8,567 | $2,300.54 | 41 |
| Potassium Chloride | Potassium Chloride | 109 | 6,967 | $2,153.77 | 33 |
| Furosemide | Furosemide | 82 | 4,440 | $631.83 | 21 |
| Kerendia | Finerenone | 81 | 2,610 | $54,849.41 | 16 |
| Lisinopril | Lisinopril | 69 | 5,423 | $815.96 | 20 |
| Carvedilol | Carvedilol | 66 | 4,267 | $673.46 | 19 |
| Torsemide | Torsemide | 62 | 3,382 | $960.58 | 21 |
| Chlorthalidone | Chlorthalidone | 56 | 3,585 | $771.72 | 12 |
| Prosol | Parenteral Amino Acid 20% No.1 | 56 | 389 | $11,961.55 | — |
| Nebivolol Hcl | Nebivolol Hcl | 37 | 1,800 | $1,067.02 | — |
| Minoxidil | Minoxidil | 35 | 1,470 | $438.46 | — |
| Allopurinol | Allopurinol | 29 | 2,230 | $221.08 | — |
| Prednisone | Prednisone | 28 | 1,200 | $94.97 | — |
| Celecoxib | Celecoxib | 27 | 990 | $225.33 | — |
| Farxiga | Dapagliflozin Propanediol | 26 | 780 | $14,622.06 | — |
| Velphoro | Sucroferric Oxyhydroxide | 23 | 690 | $36,036.40 | — |
| Calcium Acetate | Calcium Acetate | 22 | 620 | $699.77 | — |
| Terazosin Hcl | Terazosin Hcl | 19 | 667 | $105.06 | — |
| Metolazone | Metolazone | 18 | 710 | $347.14 | — |
| Potassium Citrate Er | Potassium Citrate | 18 | 600 | $879.74 | — |
| Sevelamer Carbonate | Sevelamer Carbonate | 18 | 790 | $2,359.19 | — |
| Irbesartan | Irbesartan | 15 | 1,380 | $272.80 | — |
| Simvastatin | Simvastatin | 14 | 480 | $58.36 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-03-20NUCC Taxonomy Code: 207RN0300X
An internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation.
NUCC Taxonomy Code: 207RN0300X
An internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NEPHROLOGY
I20130128000200
UT
0042116568
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Revere Health Pc
250 W 300, Roosevelt, UT 840662336
Phone: 8013774623
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Nephrology
Doctor of Osteopathic Medicine (D.O.)
Nurse Practitioner
Nurse Practitioner
Physician Assistant
Physician Assistant
Internal Medicine - Nephrology
Doctor of Osteopathic Medicine (D.O.)
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Nurse Practitioner - Family
Doctor of Nursing Practice, Advanced Practice Registered Nurse, Family Nurse Practitioner (Certified)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Internal Medicine (license number reported to NPPES: MT 11089)
Registered at 1055 N 500 W, CREDENTIALING DEPARTMENT, PROVO, UT 846043305 (Tel: 8013548225)
NPI status registered as active in NPPES database
Registered at 1055 N 500 W, STE 222, PROVO, UT 846043305 (Tel: 8013548225)
Registered at 1055 N 500 W, PROVO, UT 846043305 (Tel: 8013548225)
Recorded as WILLIAM BARAGER, DO
Internal Medicine (license number reported to NPPES: UT 8397795-1204)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Nephrology Specialists in Provo
Healthcare providers in ProvoMailing Address
1055 N 500 W, Credentialing Department
Provo, UT 846043305
Phone: 8013548225